• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醌类烷基化剂在耐醌细胞中的活性。

Activity of quinone alkylating agents in quinone-resistant cells.

作者信息

Begleiter A, Leith M K

机构信息

Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.

出版信息

Cancer Res. 1990 May 15;50(10):2872-6.

PMID:1692249
Abstract

The role of the quinone group in the antitumor activity of quinone alkylating agents, such as mitomycin C and 2,5-diaziridinyl-3,5-bis(carboethoxyamino)-1,4-benzoquinone, is still uncertain. The quinone group may contribute to antitumor activity by inducing DNA strand breaks through the formation of free radicals and/or by influencing the alkylating activity of the quinone alkylators. The cytotoxic activity and DNA damage produced by the model quinone alkylating agents, benzoquinone mustard and benzoquinone dimustard, were compared in L5178Y murine lymphoblasts sensitive and resistant to the model quinone antitumor agent, hydrolyzed benzoquinone mustard. The resistant cell lines, L5178Y/HBM2 and L5178Y/HBM10, have increased concentrations of glutathione and elevated catalase, superoxide dismutase, glutathione S-transferase, and DT-diaphorase activity. L5178Y/HBM2 and L5178Y/HBM10 cells were 7.4- and 8.5-fold less sensitive to benzoquinone mustard and 1.7- and 4.3-fold less sensitive to benzoquinone dimustard, respectively, compared with sensitive cells, but showed no resistance to the non-quinone alkylating agent, aniline mustard. The formation of DNA double strand breaks by benzoquinone mustard was reduced by 2- and 8-fold in L5178Y/HBM2 and L5178Y/HBM10 cells, respectively, while double strand break formation by benzoquinone dimustard was reduced only in the L5178Y/HBM10 cells. The number of DNA-DNA cross-links produced by benzoquinone mustard was 3- and 6-fold lower, and the number produced by benzoquinone dimustard was 35% and 2-fold lower in L5178Y/HBM2 and L5178Y/HBM10 cells, respectively, compared with L5178Y parental cells. In contrast, cross-linking by aniline mustard was unchanged in sensitive and resistant cells. Dicoumarol, an inhibitor of DT-diaphorase, increased the cytotoxic activity of both benzoquinone mustard and benzoquinone dimustard in L5178Y/HBM10 cells. This study provides evidence that elevated DT-diaphorase activity in the resistant cells contributes to resistance to benzoquinone mustard and benzoquinone dimustard, possibly by decreasing the formation of the semiquinone intermediates of these agents. The altered reduction of the quinone groups in the resistant cells may be responsible for the decreased DNA-DNA cross-linking and lowered induction of DNA strand breaks by the quinone alkylating agents. These findings demonstrate that the quinone group can modulate the activity of quinone alkylating agents. The study also suggests that the semiquinone intermediates of benzoquinone mustard and benzoquinone dimustard may be the active alkylating species of these two agents.

摘要

醌基在醌类烷基化剂(如丝裂霉素C和2,5-二氮丙啶基-3,5-双(乙氧羰基氨基)-1,4-苯醌)的抗肿瘤活性中的作用仍不确定。醌基可能通过形成自由基诱导DNA链断裂和/或通过影响醌类烷基化剂的烷基化活性来促进抗肿瘤活性。在对模型醌类抗肿瘤剂水解苯醌芥敏感和耐药的L5178Y小鼠成淋巴细胞中,比较了模型醌类烷基化剂苯醌芥和苯醌二芥产生的细胞毒性活性和DNA损伤。耐药细胞系L5178Y/HBM2和L5178Y/HBM10的谷胱甘肽浓度增加,过氧化氢酶、超氧化物歧化酶、谷胱甘肽S-转移酶和DT-黄递酶活性升高。与敏感细胞相比,L5178Y/HBM2和L5178Y/HBM10细胞对苯醌芥的敏感性分别降低了7.4倍和8.5倍,对苯醌二芥的敏感性分别降低了1.7倍和4.3倍,但对非醌类烷基化剂苯胺芥没有耐药性。在L5178Y/HBM2和L5178Y/HBM10细胞中,苯醌芥诱导的DNA双链断裂分别减少了2倍和8倍,而苯醌二芥诱导的双链断裂仅在L5178Y/HBM10细胞中减少。与L5178Y亲本细胞相比,L5178Y/HBM2和L5178Y/HBM10细胞中苯醌芥产生的DNA-DNA交联数量分别降低了3倍和6倍,苯醌二芥产生的交联数量分别降低了35%和2倍。相比之下,苯胺芥在敏感和耐药细胞中的交联没有变化。DT-黄递酶抑制剂双香豆素增加了L5178Y/HBM10细胞中苯醌芥和苯醌二芥的细胞毒性活性。这项研究提供了证据,表明耐药细胞中升高的DT-黄递酶活性可能通过减少这些药物的半醌中间体的形成,导致对苯醌芥和苯醌二芥的耐药性。耐药细胞中醌基还原的改变可能是醌类烷基化剂导致DNA-DNA交联减少和DNA链断裂诱导降低的原因。这些发现表明醌基可以调节醌类烷基化剂的活性。该研究还表明,苯醌芥和苯醌二芥的半醌中间体可能是这两种药物的活性烷基化物种。

相似文献

1
Activity of quinone alkylating agents in quinone-resistant cells.醌类烷基化剂在耐醌细胞中的活性。
Cancer Res. 1990 May 15;50(10):2872-6.
2
Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents.对醌类抗肿瘤药物耐药的L5178Y小鼠淋巴母细胞的特性研究
Cancer Res. 1988 Apr 1;48(7):1727-35.
3
Quinone-induced DNA damage and its relationship to antitumor activity in L5178Y lymphoblasts.醌诱导的DNA损伤及其与L5178Y淋巴母细胞抗肿瘤活性的关系。
Cancer Res. 1984 Jan;44(1):78-82.
4
The contribution of alkylation to the activity of quinone antitumor agents.烷基化对醌类抗肿瘤药物活性的贡献。
Can J Physiol Pharmacol. 1986 May;64(5):581-5. doi: 10.1139/y86-096.
5
Mechanisms for the modulation of alkylating activity by the quinone group in quinone alkylating agents.醌类烷基化剂中醌基对烷基化活性的调节机制。
Mol Pharmacol. 1991 Sep;40(3):454-8.
6
Cytocidal action of the quinone group and its relationship to antitumor activity.醌类的细胞杀伤作用及其与抗肿瘤活性的关系。
Cancer Res. 1983 Feb;43(2):481-4.
7
Studies on the mechanism of action of quinone antitumor agents.醌类抗肿瘤药物作用机制的研究。
Biochem Pharmacol. 1985 Aug 1;34(15):2629-36. doi: 10.1016/0006-2952(85)90559-3.
8
Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts.亲代及耐药淋巴母细胞中抗肿瘤醌类的细胞毒性机制
Br J Cancer Suppl. 1996 Jul;27:S23-7.
9
Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.生物还原型苯醌烷基化剂的构效关系研究:与细胞毒性机制相关的对DT-黄递酶介导的DNA交联和链断裂形成的影响。
Cancer Chemother Pharmacol. 2004 Mar;53(3):191-203. doi: 10.1007/s00280-003-0718-5. Epub 2003 Nov 12.
10
Increased expression of cytosolic glutathione S-transferases in drug-resistant L5178Y murine lymphoblasts: chemical selectivity and molecular mechanisms.耐药性L5178Y小鼠淋巴母细胞中胞质谷胱甘肽S-转移酶的表达增加:化学选择性和分子机制
Cancer Res. 1993 Aug 1;53(15):3530-5.

引用本文的文献

1
p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act.p53 在多柔比星诱导的心脏毒性和耐药性之间的十字路口:营养平衡的作用。
Nutrients. 2023 May 10;15(10):2259. doi: 10.3390/nu15102259.
2
Activation of microbubbles by low-level therapeutic ultrasound enhances the antitumor effects of doxorubicin.低强度治疗性超声激活微泡可增强阿霉素的抗肿瘤效果。
Eur Radiol. 2014 Nov;24(11):2739-53. doi: 10.1007/s00330-014-3334-3. Epub 2014 Aug 6.
3
A Model for NAD(P)H:Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy.
一种针对烟酰胺腺嘌呤二核苷酸磷酸(NAD(P)H):醌氧化还原酶1(NQO1)的个体化癌症化疗模型。
Drug Target Insights. 2009;4:1-8. doi: 10.4137/dti.s1146. Epub 2009 Jan 15.
4
The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines.阿霉素的生物还原激活在对白血病HL60敏感细胞系及其多药耐药亚系的细胞毒性活性中的作用。
Br J Cancer. 2005 Jul 11;93(1):89-97. doi: 10.1038/sj.bjc.6602639.
5
Induction of DT-diaphorase by 1,2-dithiole-3-thiones in human tumour and normal cells and effect on anti-tumour activity of bioreductive agents.1,2-二硫醇-3-硫酮对人肿瘤细胞和正常细胞中DT-黄递酶的诱导作用及其对生物还原药物抗肿瘤活性的影响。
Br J Cancer. 1998 Apr;77(8):1241-52. doi: 10.1038/bjc.1998.209.
6
Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts.亲代及耐药淋巴母细胞中抗肿瘤醌类的细胞毒性机制
Br J Cancer Suppl. 1996 Jul;27:S23-7.
7
Induction of DT-diaphorase by 1,2-dithiole-3-thione and increase of antitumour activity of bioreductive agents.1,2-二硫杂环戊烯-3-硫酮诱导DT-黄递酶并增强生物还原药物的抗肿瘤活性。
Br J Cancer Suppl. 1996 Jul;27:S9-14.
8
Cellular pharmacology of quinone bioreductive alkylating agents.醌生物还原烷基化剂的细胞药理学
Cancer Metastasis Rev. 1993 Jun;12(2):165-76. doi: 10.1007/BF00689808.